Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biostir is a specialized biotechnology company based in Japan that focuses on the development and supply of reagents and animal models for allergic diseases, particularly atopic dermatitis. The company is best known for its proprietary Biostir-AD ointment, which contains chemically modified house dust mite extract used to induce atopic dermatitis-like skin lesions in laboratory mice. This model is widely utilized by pharmaceutical companies and academic researchers globally to evaluate the efficacy of new dermatological treatments. Beyond its flagship induction reagents, Biostir provides contract research services (CRO) for efficacy testing in allergy and inflammation models. The company's products and services are essential tools for preclinical drug discovery in the fields of immunology and dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biostir.